Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Discover why Tempus AI Inc (NASDAQ:TEM) stock is surging today following major platform expansions and landmark clinical data ahead of ASCO 2026.